The markets may be seizing and the losses mounting, but some Citibank executives are still hauling in the cash. The New York Times reports that CEO Vikrim Pandit and other top executives were in theory only supposed to receive their salaries in 2007 due to the company''s poor performance to the tune of $20 billion in write-offs.
In reality, however, some executives came home with much more in deferred cash and equity awards in January 2008, much of defended by the compensation committee as "retention pay":
Vice Chairman Lewis Kaden: cash and equity worth $8.3 million, to top off his $500,000 salary;
Investment bank co-head Michael Klein:$19.3 million on a $212,500 salary;
Vice Chairman Steven Volk: $10.3 million non a $212,500 salary.
Others who will not be worried about paying their credit card bills:
Sallie Krawcheck: $2.9 million cash bonus, for a total compensation package of $12.5 million;
Winfried Bischoff: $2 million cash bonus to help his total reach $7.4 million;
CFO Gary Crittenden: cash bonus of $14 million for a grand total of $24.5 million.
Maybe these lucky execs can pool some of their resources that to buy some of the assets that Citibank will have to sell off to return to profitability.
Last updated: February 13, 2012: 09:37 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- SanDisk volatility low into analyst day and sales outlook
- Obama budget requests increase in Pell Grants, Inside Higher Education says
- Stoneridge sees 2012 EPS $1.10-$1.30 vs. consensus $1.13
- Stoneridge Q2 results include $1.72/sh in gains
- Stoneridge reports Q4 diluted EPS $1.56 vs. consensus 22c
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
3-14-2008 @ 6:08PM
Americas Watchdog said...
Hi Maura;
Great Blog. We have the National Mortgage Complaint Center & the Corporate Whistle Blower Center & we were thrilled to learn Citi is still paying its management.
About a week ago we started working on "auction rate preferred shares" (ARPS). Citi sold them "as just like a CD". "You can get your money back within a week". Now people who have ARPS can't get their money. We think its about a $500 billion dollar new disaster. To add insult to injury those who sold the ARPS are telling thousands & thousands of Americans who have all their money tied up in these "things".................."We will loan you 50% of what you have in our ARPS................while we sort this whole mess out".
Its good to know CITI still pays its management. They are doing a great job. Perhaps they can pay the taxes (due on April 15th) for the CITI customers who now have a tax bill, but no money to pay it.